Erythromycin
Who holds supplier records for Erythromycin? 9 organisations hold a current record for Erythromycin: an active US FDA Type II Drug Master File or a CEP. A further 14 organisations have only historical (inactive) DMF filings. 7 of them hold a valid EU Certificate of Suitability. Recorded organisation countries for current records: India (4), China (2), Poland (1), United States (1) and 1 other country (1).
Sources: FDA Drug Master File list, EDQM certification database, FDA Orange Book. Record updated 16 Nov 2026. How we read these records
Cite as: PharmaTek, “Erythromycin: DMF and CEP holder records”, record as of 16 Nov 2026, pharmatek.co.uk/directory/api/erythromycin
Reading the evidence
- 9 current records
Several organisations hold current DMFs or CEPs. Whether any is a usable source for your grade, scale and market still needs qualification.
- 7 with a company-level GMP certificate on record
These organisations have at least one current EU or UK GMP certificate somewhere. It is not matched to the site that makes this substance; check the certificate's site and scope.
Current records (9)
Organisations holding an active US FDA Type II Drug Master File or a CEP for Erythromycin. Country is the organisation's recorded country, not necessarily the manufacturing site.
- Alembic Pharmaceuticals LimitedIndiaCEP Company GMP cert on recordActive DMF 22695 · latest filing Mar 2009
- Calyx Chemicals & Pharmaceuticals Ltd.IndiaCEP Company GMP cert on recordActive DMF 20137 · latest filing Dec 2006
- HEC PHARM COChinaCEP Company GMP cert on recordActive DMF 19444 · latest filing Mar 2006
- Ningxia Qiyuan Pharmaceutical Co., Ltd.ChinaCEP Company GMP cert on recordActive DMF 22390 · latest filing Dec 2008
- Polfa Tarchomin S.A.PolandActive DMF 13409 · latest filing Sept 1998
- UNIMAX CHEMICALS PVT LTDIndiaActive DMF 27031 · latest filing Apr 2013
- United StatesCEP Company GMP cert on record
- Anuh Pharma LimitedIndiaCEP Company GMP cert on recordInactive DMF 19676 · latest filing Jul 2006
- SpainCEP Company GMP cert on record
The Sourcing Desk contacts candidates, confirms current supply, grade and site, and screens each against its regulatory record, for a buyer-paid fixed fee and never a supplier commission.
Valid CEP holder entries (7)
Certificates of Suitability on the EDQM register for Erythromycin, including the salts, esters and hydrates the register lists separately; each row shows the substance as named on the certificate. A CEP confirms the substance can be controlled by the European Pharmacopoeia monograph; it is not a GMP certificate, and the holder is not necessarily the manufacturer. 17 certificates in total, including withdrawn, expired, suspended and repeat certificates.
| Holder | Country | Certificate | Issued | EU GMP at holder's address |
|---|---|---|---|---|
| ERCROS S.A. Aranjuez | ES | CEP 2025-628 - Rev 00 Erythromycin, EBII, micronised, powder | May 2026 | Inspected Mar 2024 Spain |
| ANUH PHARMA LTD. Mumbai | IN | CEP 2005-205 - Rev 13 Erythromycin | Nov 2025 | — |
| Ningxia Qiyuan Pharmaceutical Co., Ltd. Yinchuan City | CN | CEP 2020-304 - Rev 02 Erythromycin | Jan 2024 | Inspected Sept 2024 Germany |
| AbbVie Inc. North Chicago | US | R1-CEP 1997-001 - Rev 08 Erythromycin | May 2023 | — |
| CALYX CHEMICALS AND PHARMACEUTICALS LIMITED Mumbai | IN | R1-CEP 2012-284 - Rev 00 Erythromycin | Apr 2020 | — |
| ALEMBIC PHARMACEUTICALS LIMITED Vadodara | IN | R1-CEP 2009-284 - Rev 00 Erythromycin | Jul 2017 | — |
| HEC PHARM CO., LTD. Yidu City | CN | R1-CEP 2007-153 - Rev 02 Erythromycin | Jan 2017 | — |
The GMP column shows the most recent EU GMP certificate issued for the same address as the holder, joined on the EMA location identifier printed on both documents (EudraGMDP, re-read about once a quarter; withdrawn certificates are excluded). A dash means no certificate carries that identifier, not that the site is uninspected. The holder's address is not necessarily where the substance is made.
Certification Online Database. European Directorate for the Quality of Medicines & HealthCare (EDQM), Council of Europe, (2026), URL: https://extranet.edqm.eu/publications/recherches_CEP.shtml. Accessed 16 Nov 2026. Reproduced with permission and unaltered. The EDQM and the Council of Europe accept no liability for any consequence arising from its use.
Historical records (14)
Organisations whose Type II DMFs for Erythromycin are no longer active. These show a past filing, not current supply.
Show all 14 historical records
- DIASPA TRADE MARK STRIDES ITALIA SRLInactive DMF 13314 · filed Sept 1998
- FERMIC SA DE CVInactive DMF 13457 · filed Sept 1998
- COMPANHIA INDUSTRIAL PRODUTORA DE ANTIBIOTICOS SARLInactive DMF 13406 · filed Sept 1998
- United States · Inactive DMF 13531 · filed Sept 1998
- GEORGE UHE COInactive DMF 13436 · filed Sept 1998
- NANTONG PHARMACEUTICAL FACTORYInactive DMF 13635 · filed Sept 1998
- United States · Inactive DMF 13336 · filed Sept 1998
- ABBOTT LABORATORIES CHEMICAL AND AGRICULTURAL PRODUCTS DIVInactive DMF 13509 · filed Sept 1998
- DSM CAPUA SPAInactive DMF 13446 · filed Sept 1998
- ANGUS BIOTECH INCInactive DMF 13721, 7567 · filed Sept 1998
- CIBRANInactive DMF 13665 · filed Sept 1998
- SANDOZ INDUSTRIAL PRODUCTS SPAInactive DMF 13477 · filed Sept 1998
- United States · Inactive DMF 13515 · filed Sept 1998
- ABBOTT LABORATORIES PHARMACEUTICAL PRODUCTS DIVInactive DMF 2904 · filed Apr 1977
Overview
Erythromycin is a small molecule active pharmaceutical ingredient (ChEMBL CHEMBL532).
Chemical identity
- IUPAC name
- (3R,4S,5S,6R,7R,9R,11R,12R,13S,14R)-6-[(2S,3R,4S,6R)-4-(dimethylamino)-3-hydroxy-6-methyloxan-2-yl]oxy-14-ethyl-7,12,13-trihydroxy-4-[(2R,4R,5S,6S)-5-hydroxy-4-methoxy-4,6-dimethyloxan-2-yl]oxy-3,5,7,9,11,13-hexamethyl-oxacyclotetradecane-2,10-dione
- Canonical SMILES
- CC[C@@H]1[C@@]([C@@H]([C@H](C(=O)[C@@H](C[C@@]([C@@H]([C@H]([C@@H]([C@H](C(=O)O1)C)O[C@H]2C[C@@]([C@H]([C@@H](O2)C)O)(C)OC)C)O[C@H]3[C@@H]([C@H](C[C@H](O3)C)N(C)C)O)(C)O)C)C)O)(C)O
- InChIKey
- ULGZDMOVFRHVEP-RWJQBGPGSA-N
- Synonyms
- Akne-mycin, Aknemycin plus, A/t/s, C-solve-2, E-base, E-glades, Emgel, E-mycin, Eritromicina, Eryacne 2, Eryacne 4, Eryc
Pharmacologic class
As the US FDA states it for this active substance on product listings.
- Established pharmacologic class
- Macrolide; Macrolide Antimicrobial
- Physiologic effect
- Decreased Sebaceous Gland Activity
- Chemical structure
- Macrolides
Record history
No change to the current records between 13 Nov 2026 and 16 Nov 2026.
Get an email when these records change: at most one a week, only when something changed, and only after you confirm your address. All changes this week
What these records establish
- An active DMF means a confidential file is held by the FDA and can be referenced; the FDA does not approve or disapprove DMFs.
- A CEP confirms monograph suitability for the EU market; it is not a GMP certificate, and the holder may not be the manufacturer.
- Historical records show a past filing, not current supply.
- Company GMP certificates are matched to the organisation, not to the site making this substance.
- A substance missing from these registers is not evidence that no supplier exists.
Frequently asked questions
Which organisations hold current supplier records for Erythromycin?
9 organisations hold an active US FDA Type II Drug Master File or a CEP for Erythromycin: Alembic Pharmaceuticals Limited (India), Calyx Chemicals & Pharmaceuticals Ltd. (India), HEC PHARM CO (China), Ningxia Qiyuan Pharmaceutical Co., Ltd. (China), Polfa Tarchomin S.A. (Poland), UNIMAX CHEMICALS PVT LTD (India), Abbvie Inc. (United States) and Anuh Pharma Limited (India), and 1 more listed on this page. A DMF or CEP shows a regulatory filing, not current commercial availability, and the holder is not necessarily the manufacturing site.
Which Erythromycin Drug Master Files are active?
Alembic Pharmaceuticals Limited (DMF 22695), Calyx Chemicals & Pharmaceuticals Ltd. (DMF 20137), HEC PHARM CO (DMF 19444), Ningxia Qiyuan Pharmaceutical Co., Ltd. (DMF 22390), Polfa Tarchomin S.A. (DMF 13409) and UNIMAX CHEMICALS PVT LTD (DMF 27031). The FDA does not approve or disapprove DMFs; an active DMF can be referenced in an application once its holder issues a letter of authorisation.
What do the historical Erythromycin records mean?
14 organisations have only inactive Type II DMFs for Erythromycin. An inactive DMF records that a filing once existed; it does not show that the organisation supplies the substance today.
Does Erythromycin have a European Certificate of Suitability?
Yes. 7 organisations hold a valid CEP for Erythromycin on the EDQM register, including ERCROS S.A. Aranjuez (ES), ANUH PHARMA LTD. Mumbai (IN), Ningxia Qiyuan Pharmaceutical Co., Ltd. Yinchuan City (CN), AbbVie Inc. North Chicago (US), CALYX CHEMICALS AND PHARMACEUTICALS LIMITED Mumbai (IN) and ALEMBIC PHARMACEUTICALS LIMITED Vadodara (IN) and 1 more. A CEP confirms the substance can be controlled by the European Pharmacopoeia monograph; it is not a GMP certificate, and the holder is not necessarily the manufacturer.
How do I qualify a Erythromycin supplier?
Confirm the DMF or CEP is current and covers your grade, obtain the letter of authorisation, identify the actual manufacturing site and check its GMP certificate and FDA inspection history, audit the site or review a recent audit, and run comparable requests for information across more than one candidate.
Do you supply Erythromycin?
Send a link to a certificate, registration or filing we have missed or got wrong. We check it against the issuing register before changing anything; information we cannot check against a register is shown as supplier-reported.